These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 2987559)

  • 1. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
    Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
    N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses.
    Sullivan JL; Brewster FE; Brettler DB; Forsberg AD; Cheeseman SH; Byron KS; Baker SM; Willitts DL; Lew RA; Levine PH
    J Pediatr; 1986 Apr; 108(4):504-10. PubMed ID: 3007715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
    Ikegami N
    AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
    Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
    JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
    Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
    J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibodies to HTLV-I and -III in sera from Japanese hemophiliacs.
    Abe T; Kinoshita T; Matsuda J; Ryu T; Ting RC; Aoki T; Robert-Guroff M; Miyakoshi H; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4621s-4623s. PubMed ID: 2990696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune status of blood product recipients.
    Jason J; Hilgartner M; Holman RC; Dixon G; Spira TJ; Aledort L; Evatt B
    JAMA; 1985 Feb; 253(8):1140-5. PubMed ID: 3918187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate.
    Goedert JJ; Sarngadharan MG; Eyster ME; Weiss SH; Bodner AJ; Gallo RC; Blattner WA
    Blood; 1985 Feb; 65(2):492-5. PubMed ID: 2981592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
    Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ
    Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.
    Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Goldstein AL; Naylor PH; Preble O; Stewart JA; Essex M
    Am J Med; 1986 Mar; 80(3):345-50. PubMed ID: 3006485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
    J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV III antibodies and immunological alterations in hemophilia patients.
    Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
    Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses.
    Stein SF; Evatt BL; McDougal JS; Lawrence DN; Holman RC; Ramsey RB; Spira TJ
    Blood; 1985 Oct; 66(4):973-9. PubMed ID: 2994784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrovirus infections among patients treated in Britain with various clotting factors.
    Cheinsong-Popov R; Tedder RS; O'Connor T; Clayden S; Smith A; Craske J; Weiss R
    Br Med J (Clin Res Ed); 1986 Jul; 293(6540):168-9. PubMed ID: 3015319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS and haemophilia.
    Carr R
    Biomed Pharmacother; 1985; 39(7):347-50. PubMed ID: 3006817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
    Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN
    Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.
    Volsky DJ; Wu YT; Sinangil F; Goldsmith JC
    AIDS Res; 1986 Feb; 2(1):51-61. PubMed ID: 2424467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T-cell leukemia virus (HTLV-I) p24 antibody in New York City blood product recipients.
    Jason JM; McDougal JS; Cabradilla C; Kalyanaraman VS; Evatt BL
    Am J Hematol; 1985 Oct; 20(2):129-37. PubMed ID: 2994470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.